Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531). (Q37321794)
Jump to navigation
Jump to search
scientific article published on 15 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531). |
scientific article published on 15 December 2008 |
Statements
1 reference
Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer (N0531). (English)
1 reference
V Roy
1 reference
B R LaPlant
1 reference
G G Gross
1 reference
C L Bane
1 reference
F M Palmieri
1 reference
North Central Cancer Treatment Group
1 reference
1 reference
1 reference
Identifiers
1 reference